Prasugrel: all 112 studies that test it
Page 2 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MICompletedNCT01327534Phase 3
- The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic AsthmaCompletedNCT01305369Phase 4
- Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel TreatmentCompletedNCT01304472Phase 3
- Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.CompletedNCT01175200Not applicable
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMIStatus unknownNCT01158846Phase 4
- Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic HemodialysisCompletedNCT01155765Phase 3
- Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCICompletedNCT01135667Phase 4
- Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).CompletedNCT01109784Phase 3
- Plavix, Prasugrel and Drug Eluting Stents Pilot TrialStatus unknownNCT01103843Not applicable
- The Role of the P2Y12 Receptor in Tissue Factor Induced CoagulationCompletedNCT01099566Phase 4
- Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial InfarctionStatus unknownNCT00976092Phase 4
- Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet TherapyCompletedNCT00827411Phase 4